Skip to main content

Advertisement

Log in

Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphen citrate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial

  • Infertility
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Objective

To study the efficacy of the aromatase inhibitor letrozole in controlled ovarian hyperstimulation (COH).

Material and methods

In this prospective simply randomized clinical trial, one hundred forty patients with unexplained infertility undergoing intrauterine insemination (IUI) therapy were randomized to receive either letrozole or clomiphene citrate (CC)-gonadotropin. The patients were selected among patients referred to one university hospital and one private infertility clinic. A letrozole dose of 5 mg/day (n = 70) was given on days 3–7 of the menstrual cycles. Clomiphen citrate a dose of 100 mg/day was given like letrozole but combined with human menopausal gonadotropin (hMG) dose of 75 IU/ml administered every day starting on day 6. Ovulation was triggered with urinary hCG (10,000 IU) when the leading follicle(s) reached 18 mm in diameter. A single IUI was performed 36 hours later. The luteal phase was supplemented with micronized progesterone vaginally. Ovarian stimulation response (E2 levels and number of follicles) was primary outcome.

Results

There were no differences in demographic characteristics between groups. The number of mature follicles (1.8 ± 0.7 vs. 2.46 ± 2.3; P = 0.042) and serum E2 level on the day of hCG (310 ± 135.4 vs. 1,670.7 ± 1021.8 pg/ml, respectively; P < 0.0001) were significantly lower in letrozole group. A significantly higher endometrial thickness was observed at the time of hCG administration in patients that received letrozole (9.7 ± 1.6 mm vs. 7.8 ± 2 mm; P < 0.001).Clinical pregnancy rates also were significantly higher in letrozole group (32.8% vs. 14.3%, respectively; P < 0.01).

Conclusion

The aromatase inhibitor letrozole appears to constitute a good alternative to CC-gonadotropin in patients with unexplained infertility undergoing COH cycles combined with IUI therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beck JI, Boothroyd C, Proctor M, Farquhar C, Hughes E. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 2005;25(1):CD002249.

    Google Scholar 

  2. Dickey RP, Taylor SN, Curole DN, Rye PH, Pyrzak R. Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod 1996;11(12):2623–8.

    PubMed  CAS  Google Scholar 

  3. Gorlitsky GA, Kase NG, Speroff L. Ovulation and pregnancy rates with clomiphene citrate. Obstet Gynecol 1978;51(3):265–9.

    Article  PubMed  CAS  Google Scholar 

  4. Garcia J, Jones GS, Wentz AC. The use of clomiphene citrate. Fertil Steril 1977;28(7):707–17.

    PubMed  CAS  Google Scholar 

  5. Hammond MG. Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction. Fertil Steril 1984;42(4):499–509.

    PubMed  CAS  Google Scholar 

  6. Gysler M, March CM, Mishell DR, Bailey EJ. A decades experience with an individualized clomiphene treatment regimen including its effects on the postcoital teat. Fertil Steril 1982;37:161–7.

    PubMed  CAS  Google Scholar 

  7. Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril 1991;56(3):465–8.

    PubMed  CAS  Google Scholar 

  8. Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990;5(6):670–4.

    PubMed  CAS  Google Scholar 

  9. Eden JA, Place J, Carter GD, Jones J, Alaghband-Zadeh J, Pawson ME. The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume. Obstet Gynecol. 1989;73(2):187–90.

    PubMed  CAS  Google Scholar 

  10. Opsahl MS, Robins ED, O’Connor DM, Scott RT, Fritz MA. Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril 1996;66(4):533–9.

    PubMed  CAS  Google Scholar 

  11. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75(2):305–9.

    Article  PubMed  CAS  Google Scholar 

  12. Casper RF. Letrozole: ovulation or superovulation? Fertil Steril 2003 Dec;80(6):1335–7.

    Article  PubMed  Google Scholar 

  13. Mitwally MF, Casper RF. Aromatase inhibitors in ovulation induction. Semin Reprod Med 2004;22(1):61–78.

    Article  PubMed  CAS  Google Scholar 

  14. Kilic-Okman T, Kucuk M, Altaner S. Comparison of the effects of letrozole and clomiphene citrate on ovarian follicles, endometrium, and hormone levels in the rat. Fertil Steril 2003;80(6):1330–2.

    Article  PubMed  Google Scholar 

  15. Ivoson T, Smith I, Ahern J, Smithers D, Trunel P, Dowseh M. Phase I study of the oral nonsteroidal aromatase inhibiter COS 20267 in post menopausal patients with advanced breast cancer. Cancer Res 1993;53:266–70.

    Google Scholar 

  16. Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003;18(8):1588–97.

    Article  PubMed  CAS  Google Scholar 

  17. Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril 2006;85(6):1774–7.

    Article  PubMed  CAS  Google Scholar 

  18. Netter J. Applied linear statistical models. Richard D. Irwin Inc., Homewood, IL, USA; 1974. p. 833.

    Google Scholar 

  19. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005;23(19):4347–53.

    Article  PubMed  CAS  Google Scholar 

  20. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005;192(2):381–6.

    Article  PubMed  CAS  Google Scholar 

  21. Sohrabvand F, Ansari Sh, Bagheri M. Efficacy of combined metformin–letrozole in comparison with metformin–clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod. 2006;21(6):1432–5.

    Article  PubMed  CAS  Google Scholar 

  22. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002;78(2):280–5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This research has been supported by Tehran University of Medical Sciences and we would like to thank the staff of Vali-e Asr infertility Research Center and The Royan Institute for their cooperation throughout the stages of the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ensieh Sh. Tehrani nejad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sh. Tehrani nejad, E., Abediasl, Z., Rashidi, B.H. et al. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphen citrate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial. J Assist Reprod Genet 25, 187–190 (2008). https://doi.org/10.1007/s10815-008-9209-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-008-9209-2

Keywords

Navigation